| |
| Issue |
Title |
| |
| No 16 (2023) |
Features of management of patients with cardiometabolic polymorbidity phenotype: focus on the efficacy and safety of bisoprolol |
Abstract
PDF (Rus)
|
|
O. A. Polyakova, O. D. Ostroumova |
| |
| No 16 (2023) |
Problems in the diagnosis of secondary arterial hypertension of adrenal origin |
Abstract
PDF (Rus)
|
|
L. A. Sharonova, S. V. Bulgakova, Yu. A. Dolgikh, O. V. Kosareva |
| |
| No 14 (2021) |
Arterial hypertension: modern advances in metabolomics |
Abstract
PDF (Rus)
|
|
S. K. Zyryanov, O. I. Butranova, M. A. Grishin |
| |
| No 14 (2021) |
Prospects for the use of a fixed combination of bisoprolol and amlodipine in the treatment of patients with post-covid syndrome |
Abstract
PDF (Rus)
|
|
O. A. Polyakova, O. D. Ostroumova, E. V. Mironova, N. M. Doldo, A. I. Listratov, A. V. Filippov |
| |
| No 14 (2021) |
Hemodynamic effects of combined antihypertensive therapy during exercise in men with arterial hypertension and chronic venous diseases |
Abstract
PDF (Rus)
|
|
S. V. Letyagina, V. M. Baev, T. Y. Agafonova |
| |
| No 16 (2019) |
Current perspectives on fixed-dose ACE inhibitordiuretic combination therapy in the management of arterial hypertension |
Abstract
PDF (Rus)
|
|
G. N. Gorokhovskaya, V. L. Yun, A. I. Martynov, Yu. A. Vasyuk, S. V. Moiseenko |
| |
| No 5 (2019) |
Possibilities of using Fosinopril, an angiotensinconverting enzyme inhibitor, combined with Diltiazem, a non-dihydropyridine calcium antagonist, as first-line therapy in the treatment of arterial hypertension (clinical case) |
Abstract
PDF (Rus)
|
|
O. D. Ostroumova, I. V. Goloborodova |
| |
| No 5 (2019) |
New targets and old therapies for arterial hypertension |
Abstract
PDF (Rus)
|
|
S. R. Gilyarevsky, N. G. Bendeliani, M. V. Golshmid, G. Yu. Zakharova, I. M. Kuzmina, I. I. Sinitsina |
| |
| No 5 (2019) |
Adherence to taking medicines as a basis for prevention of cardiovascular diseases |
Abstract
PDF (Rus)
|
|
D. A. Napalkov, A. A. Sokolova |
| |
| No 16 (2018) |
Cerebroprotective effects of angiotensin II receptor blockers: candesartan focus |
Abstract
PDF (Rus)
|
|
O. D. Ostroumova, A. I. Kochetkov, T. M. Ostroumova, E. E. Pavleeva |
| |
| No 16 (2018) |
Organization of pharmacological support of patients with rare diseases in moscow as exemplified by pulmonary arterial hypertension |
Abstract
PDF (Rus)
|
|
M. V. Zhuravleva, A. Yu. Lebedeva |
| |
| No 7 (2017) |
CANDESARTAN IN CARDIOLOGY PRACTICE |
Abstract
PDF (Rus)
|
|
N. A. Dzhaiani |
| |
| No 7 (2017) |
THE PLACE OF FOSINOPRIL IN EVIDENCE-BASED TREATMENT OF PATIENTS WITH ARTERIAL HYPERTENSION |
Abstract
PDF (Rus)
|
|
S. A. Berns, R. I. Stryuk |
| |
| No 7 (2017) |
COMBINATION THERAPY OF AH IN CLINICAL PRACTICE |
Abstract
PDF (Rus)
|
|
Y. A. Karpov, O. S. Bulkina |
| |
| No 12 (2017) |
CHRONIC RENAL DISEASE: RISK FACTORS, EARLY DETECTION, PRINCIPLES OF ANTIHYPERTENSIVE THERAPY |
Abstract
PDF (Rus)
|
|
A. M. Easyan |
| |
| No 12 (2017) |
THERAPY OF ARTERIAL HYPERTENSION AND PREVENTION OF CARDIOVASCULAR DISEASES IN WOMAN OF REPRODUCTIVE AGE SUFFERING FROM MIGRAINE. CLINICAL REVIEW |
Abstract
PDF (Rus)
|
|
O. A. Kislyak, A. V. Starodubova, Y. B. Chervyakova |
| |
| No 12 (2017) |
PECULIARITIES OF ANTIHYPERTENSIVE THERAPY INDICATED IN THERAPEUTIC AND SURGICAL DEPARTMENTS OF THE UNIVERSITY CLINICAL HOSPITAL |
Abstract
PDF (Rus)
|
|
N. A. Morina, O. D. Savkova, E. A. Fedorova, I. L. Tsarev, A. B. Frolkova, A. E. Tsygankova, A. A. Sokolova, D. A. Napalkov, V. V. Fomin |
| |
| No 13 (2016) |
THREE-COMPONENT ANTI-HYPERYTENSION THERAPY – PROSPECTS OF APPLICATION |
Abstract
PDF (Rus)
|
|
I. I. CHUKAEVA, F. D. AKHMATOVA, Y. G. SPIRYAKINA |
| |
| No 13 (2016) |
COMBINED AND ORGAN-PROTECTIVE ANTI-HYPERTENSION THERAPY: POSSIBILITIES OF FIXED COMBINATION OF NITRENDIPINE AND ENALAPRIL |
Abstract
PDF (Rus)
|
|
A. G. EVDOKIMOVA, G. V. ARKADIEVA, V. V. EVDOKIMOV, А. N. DOBASHIN |
| |
| No 13 (2016) |
THE USE OF BETA-BLOCKER BISOPROLOL FOR THE PREVENTION OF HIGH BLOOD PRESSURE IN WOMEN WITH IDIOPATHIC ARTERIAL HYPOTENSION |
Abstract
PDF (Rus)
|
|
M. P. SAVENKOV, S. N. IVANOV, Z. V. POSTNIKOVA, M. N. PALKIN, S. V. IVANOVA, M. V. BORSCHEVSKAYA, I. N. OKUNEVA, L. A. SOLOMONOVA, A. M. SAVENKOVA |
| |
| No 13 (2016) |
TREATMENT OF HYPERTENSIVE PATIENTS WITH HIGH OR VERY HIGH CARDIOVASCULAR RISK. PHARMACOECONOMIC EFFICIENCY OF A TRIPLE COMBINATION THERAPY CONTAINING ANGIOTENSIN CONVERTING ENZYME INHIBITOR, CALCIUM CHANNEL BLOCKER AND STATIN |
Abstract
PDF (Rus)
|
|
I. N. DYAKOV |
| |
| No 13 (2016) |
STATE OF OXYDATIVE STRESS IN HYPERTONIC DISEASE COMPLICATED BY TRANSITORY ISCHEMIC ATTACKS |
Abstract
PDF (Rus)
|
|
A. I. MARTYNOV, V. L. YUN, G. N. GOROKHOVSKAYA, E. Y. MAYCHUK, D. A. MARTYNOV |
| |
| No 13 (2016) |
EFFECTIVENESS OF FIXED COMBINATION OF RAMIPIL/AMLODIPINE IN THERAPY OF ARTERIAL HYPERTENSION, CHRONIC KIDNEY DISEASE AND DIABETES MELLITUS |
Abstract
PDF (Rus)
|
|
O. D. OSTROUMOVA, A. A. ZYKOV |
| |
| No 12 (2015) |
The choice of combination antihypertensive therapy in patients with type 2 diabetes |
Abstract
PDF (Rus)
|
|
O. A. Koshelskaya, O. A. Zhuravleva, R. S. Karpov |
| |
| No 12 (2015) |
Diabetes and hypertension |
Abstract
PDF (Rus)
|
|
E. A. Ermakova, A. S. Ametov, N. A. Chernikova |
| |
| No 12 (2015) |
Combination therapy of hypertension |
Abstract
PDF (Rus)
|
|
O. O. Bolshakova |
| |
| No 12 (2015) |
Current approach to antihypertensive therapy |
Abstract
PDF (Rus)
|
|
M. V. Kuznetsova |
| |
| No 12 (2015) |
The role of fosinopril in the treatment and prevention of cardiovascular diseases |
Abstract
PDF (Rus)
|
|
G. A. Baryshnikova |
| |
| No 12 (2014) |
Diuretics in the treatment of patients with arterial hypertension: results of the DOVERIE comparative study |
Abstract
PDF (Rus)
|
|
OP Shevchenko, EE Averin, VA Vygodin |
| |
| No 12 (2014) |
Clinical pharmacology and clinical efficacy of amlodipine. Evidence-based data |
Abstract
PDF (Rus)
|
|
MV Leonova |
| |
| No 12 (2014) |
Dabigatran etexilate in the prevention of cardioembolic complications in patients with non-valvular atrial fibrillation |
Abstract
PDF (Rus)
|
|
IS Yavelov |
| |
| No 12 (2014) |
Use of clopidogrel generics in patients with acute coronary syndrome: have all issues have been resolved? |
Abstract
PDF (Rus)
|
|
AN Yakovlev |
| |
| No 12 (2014) |
Place of the novel drug ranolazine in the treatment of coronary artery disease |
Abstract
PDF (Rus)
|
|
GA Baryshnikova, SA Chorbinskaya, II Stepanova |
| |
| No 12 (2014) |
Pain in angina attack |
Abstract
PDF (Rus)
|
|
MV Kuznetsova |
| |
| No 12 (2014) |
Molsidomine in the treatment of patients with stable coronary artery disease |
Abstract
PDF (Rus)
|
|
VP Lupanov |
| |
| No 12 (2014) |
The problem of choosing an anticoagulant for stroke prevention in patients with atrial fibrillation |
Abstract
PDF (Rus)
|
|
EL Dolgova, IM Sokolov, YG Schwarz |
| |
| No 12 (2014) |
Patient-specific choice of an antiplatelet drug for long-term therapy of coronary heart disease: rationale and implementationL |
Abstract
PDF (Rus)
|
|
NA Mazur |
| |
| 1 - 37 of 37 Items |
|
